Molly
A reported 17,500 women take Avastin for metastatic breast cancer. The drug’s manufacturer, Genentech, should surely be able to prove to the FDA the effectiveness of their drug. Come on Genentech- you have 17,500 women on the drug so you should easily be able to prove its effectiveness.